Overview
No overview information available.
Indication
用于：1.各种原因引起的中性粒细胞减少证，如恶性肿瘤和白血病化疗与放疗引起的中性粒细胞减少、造血干/祖细胞移植后髓系造血功能的受抑及延迟植活鱼移植排斥； 2.周围血造血干/祖细胞移植前的干/祖细胞动员等； 3.骨髓增生异常综合征（MDS）、再生障碍性贫血伴发的中性粒细胞减少，先天性、特发性、周期性中性粒细胞减少症，但远期疗效不肯定； 4.各种严重感染，包括艾滋病及并发的感染； 5.抗艾滋病药物引起的中性粒细胞减少症也可应用。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/07/17 | N/A | Not yet recruiting | |||
2023/11/07 | Phase 2 | Completed | Trio Fertility | ||
2023/09/07 | Phase 4 | Recruiting | Chongqing University Cancer Hospital | ||
2023/04/28 | Not Applicable | Not yet recruiting | Ou Bai, MD/PHD | ||
2021/12/14 | Not Applicable | UNKNOWN | Sun Yat-sen University | ||
2020/09/09 | Phase 2 | Completed | Chongqing University Cancer Hospital | ||
2020/08/05 | Not Applicable | UNKNOWN | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | ||
2020/08/04 | Not Applicable | UNKNOWN | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | ||
2020/07/07 | Phase 2 | UNKNOWN | |||
2019/09/10 | Phase 4 | UNKNOWN |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.